Li et al. evaluated the efficacy of intrapleural injection of anti-PD-1 antibodies in MPE in a mouse model and in 9 patients with MPE due to non-small cell lung cancer [31]. This evidence concerns the gene PDCD1 and non-small cell lung carcinoma.